Maitreya Medicare Ltd

Maitreya Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Maitreya Medicare Ltd

₹ 340 3.56%
22 Nov - close price
Company website NSE - SME: MAITREYA
About

Incorporated in 2019, Maitreya Medicare Ltd is an integrated multispeciality hospital with primary secondary & tertiary care situated in Surat, Gujrat.[1]

Key Points

Integrated Healthcare Provider[1] Maitreya Medicare offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Laparoscopic Surgery, Oncology, Neurosurgery, Spine Surgery, Neurology, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine, etc.

Website NSE - ST
  • Market Cap ₹ 231 Cr.
  • Current Price ₹ 340
  • High / Low ₹ 400 / 111
  • Stock P/E 73.7
  • Book Value ₹ 47.2
  • Dividend Yield 0.00 %
  • ROCE 18.0 %
  • ROE 18.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 30.5%

Cons

  • Stock is trading at 7.21 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Debtor days have increased from 80.7 to 108 days.
  • Working capital days have increased from 46.7 days to 84.1 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023 Sep 2024
24.79 24.36
20.23 21.18
Operating Profit 4.56 3.18
OPM % 18.39% 13.05%
0.05 0.19
Interest 0.39 0.45
Depreciation 0.64 0.66
Profit before tax 3.58 2.26
Tax % 28.49% 26.11%
2.56 1.67
EPS in Rs 5.16 2.46
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024
55.93 49.35 39.28 46.13
48.68 45.98 32.02 39.93
Operating Profit 7.25 3.37 7.26 6.20
OPM % 12.96% 6.83% 18.48% 13.44%
0.43 0.33 0.53 0.30
Interest 0.82 0.78 0.57 0.84
Depreciation 1.09 1.32 1.29 1.27
Profit before tax 5.77 1.60 5.93 4.39
Tax % 26.52% 28.75% 28.16% 27.79%
4.24 1.14 4.25 3.17
EPS in Rs 4,240.00 1,140.00 8.57 4.68
Dividend Payout % 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: -6%
TTM: 17%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -9%
TTM: -27%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 162%
Return on Equity
10 Years: %
5 Years: %
3 Years: 30%
Last Year: 19%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 0.01 0.01 4.96 6.78 12.22
Reserves 3.85 4.70 3.81 18.07 19.74
14.24 12.38 11.59 11.10 5.66
7.17 7.40 8.55 7.91 9.36
Total Liabilities 25.27 24.49 28.91 43.86 46.98
13.84 13.40 11.60 14.32 15.05
CWIP 0.00 0.00 0.00 0.00 0.00
Investments 1.07 0.32 0.68 1.47 0.04
10.36 10.77 16.63 28.07 31.89
Total Assets 25.27 24.49 28.91 43.86 46.98

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024
4.45 0.08 2.59 -2.15
-5.07 -0.02 0.36 -5.44
2.16 -1.86 -1.59 12.21
Net Cash Flow 1.55 -1.80 1.36 4.62

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 31.91 43.42 90.41 108.40
Inventory Days 68.78 40.82 69.86 40.26
Days Payable 258.06 221.84 319.59 207.25
Cash Conversion Cycle -157.37 -137.61 -159.32 -58.59
Working Capital Days 3.65 12.28 43.58 84.11
ROCE % 12.33% 32.85% 18.00%

Shareholding Pattern

Numbers in percentages

1 Recently
Mar 2024Sep 2024
73.11% 73.11%
2.53% 0.41%
1.35% 0.00%
23.02% 26.48%
No. of Shareholders 474907

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls